Healthcare Infection Control Practices Advisory Committee (HICPAC), 9477 [2016-03929]
Download as PDF
<![CDATA[
9477
Federal Register / Vol. 81, No. 37 / Thursday, February 25, 2016 / Notices
eliminate existing barriers to treatment
so that young women have access to
high quality breast cancer treatment and
care. Results will also be used to
improve care and services provided to
young women diagnosed with breast
cancer. Study findings will be
disseminated through reports,
presentations, and publications.
OMB approval is requested for one
year. Participation is voluntary and
there are no costs to respondents other
than their time. The total estimated
annualized burden hours are 1,241.
ESTIMATED TOTAL BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Sample 1—Breast cancer survivors recruited
from state cancer registries.
Sample 2—Breast cancer survivors associated with advocacy groups (ineligibles).
Sample 2—Breast cancer survivors associated with advocacy groups (eligible and
complete).
Breast Cancer in Young Women Survey
(Mail-in or web-based questionnaire).
Breast Cancer in Young Women Survey
(Screener only).
Breast Cancer in Young Women Survey
(Screener and Web-based questionnaire).
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–04013 Filed 2–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a) (2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Times and Dates: 9:00 a.m.–5:00 p.m.,
EDT, March 31, 2016; 9:00 a.m.–12:00 p.m.,
EDT, April 1, 2016.
Place: Centers for Disease Control and
Prevention, Global Communications Center,
Building 19, Auditorium B, 1600 Clifton
Road NE., Atlanta, Georgia, 30333.
Status: Open to the public, limited only by
the space available. Please register for the
meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with
providing advice and guidance to the
Director, Division of Healthcare Quality
Promotion, the Director, National Center for
Emerging and Zoonotic Infectious Diseases
(NCEZID), the Director, CDC, the Secretary,
Health and Human Services regarding (1) the
practice of healthcare infection prevention
and control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of CDC guidelines and
other policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
VerDate Sep<11>2014
18:07 Feb 24, 2016
Jkt 238001
Matters for Discussion: The agenda will
include updates on CDC’s activities for
prevention of healthcare associated
infections (HAIs), updates on antimicrobial
stewardship, an update on Draft Guideline
for Prevention of Infections in Healthcare
Personnel, chlorhexidine gluconateimpregnated dressings, and an update from
the workgroup for considerations on
endoscope reprocessing.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Erin
Stone, M.S., HICPAC, Division of Healthcare
Quality Promotion, NCEZID, CDC, 1600
Clifton Road NE., Mailstop A–07, Atlanta,
Georgia 30333. Telephone (404) 639–4045.
Email: hicpac@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–03929 Filed 2–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff,
Announces the Following Meeting
Name: ICD–10 Coordination and
Maintenance (C&M) Committee meeting.
Time and Date: 9:00 a.m.–5:00 p.m.,
EST, March 9–10, 2016.
Place: Centers for Medicare and
Medicaid Services (CMS) Auditorium,
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
1,200
1
22/60
25
1
2/60
2,000
1
24/60
7500 Security Boulevard, Baltimore,
Maryland 21244.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 240
people. We will be broadcasting the
meeting live via Webcast at https://
www.cms.gov/live/.
Security Considerations: Due to in
creased security requirements CMS has
instituted stringent procedures for
entrance into the building by nongovernment employees. Attendees will
need to present valid government-issued
picture identification, and sign-in at the
security desk upon entering the
building.
Attendees who wish to attend the
March 9–10, 2016 ICD–10–CM C&M
meeting must submit their name and
organization by March 1, 2016 for
inclusion on the visitor list. This visitor
list will be maintained at the front desk
of the CMS building and used by the
guards to admit visitors to the meeting.
Participants who attended previous
Coordination and Maintenance meetings
will no longer be automatically added to
the visitor list. You must request
inclusion of your name prior to each
meeting you wish attend.
Please register to attend the meeting
on-line at: https://www.cms.hhs.gov/
apps/events/. Please contact Mady Hue
(410–786–4510 or Marilu.hue@
cms.hhs.gov), for questions about the
registration process.
Purpose: The ICD–10 Coordination
and Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Tenth Revision, Clinical Modification
and ICD–10 Procedure Coding System.
Matters for Discussion: Agenda items
include: March 9–10, 2016.
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 81, Number 37 (Thursday, February 25, 2016)]
[Notices]
[Page 9477]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03929]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a) (2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting for the aforementioned
committee:
Times and Dates: 9:00 a.m.-5:00 p.m., EDT, March 31, 2016; 9:00
a.m.-12:00 p.m., EDT, April 1, 2016.
Place: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road
NE., Atlanta, Georgia, 30333.
Status: Open to the public, limited only by the space available.
Please register for the meeting at www.cdc.gov/hicpac.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion,
the Director, National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID), the Director, CDC, the Secretary, Health and
Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related
events in settings where healthcare is provided; and (3) periodic
updating of CDC guidelines and other policy statements regarding
prevention of healthcare-associated infections and healthcare-
related conditions.
Matters for Discussion: The agenda will include updates on CDC's
activities for prevention of healthcare associated infections
(HAIs), updates on antimicrobial stewardship, an update on Draft
Guideline for Prevention of Infections in Healthcare Personnel,
chlorhexidine gluconate-impregnated dressings, and an update from
the workgroup for considerations on endoscope reprocessing.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.S., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia 30333. Telephone (404)
639-4045. Email: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2016-03929 Filed 2-24-16; 8:45 am]
BILLING CODE 4163-18-P
